Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy–causing mutations in the β-myosin.

Slides:



Advertisements
Similar presentations
Connexin Mutations in Skin Disease and Hearing Loss David P. Kelsell, Wei-Li Di, Mark J. Houseman The American Journal of Human Genetics Volume 68, Issue.
Advertisements

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.
Gene Preference in Maple Syrup Urine Disease Mary M. Nellis, Dean J. Danner The American Journal of Human Genetics Volume 68, Issue 1, Pages (January.
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Chronic Lyme Disease: A Survey of Connecticut Primary Care Physicians Michael Johnson, MD, Henry M. Feder, MD The Journal of Pediatrics Volume 157, Issue.
Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical Features of Hypertrophic Cardiomyopathy.
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Frequency and clinical expression of cardiac troponin.
Accuracy of 64-row multidetector computed tomography in detecting coronary artery disease in 134 symptomatic patients: Influence of calcification  Tiong.
Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation.
Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal.
The potential of social networks for early warning nad outbreak detection systems: the swine flu Twitter study  P. Kostkova, E. de Quincey, G. Jawaheer 
Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST)  Kirsten E. Fleischmann,
Downstream coronary effects of drug-eluting stents
Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.
Colloquium on Therapy of Right Heart Failure
Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E
A critical review of hemodynamic changes and left ventricular remodeling after surgical aortic valve replacement and percutaneous aortic valve replacement 
Force- and relaxation-frequency relations in patients with diastolic heart failure  Takashi Yamanaka, MD, Katsuya Onishi, MD, FACC, Masaki Tanabe, MD,
Tomislav Mihaljevic, MD, Edward R
Increasing Exposure to Antibody-Stimulating Proteins and Polysaccharides in Vaccines Is Not Associated with Risk of Autism  Frank DeStefano, MD, MPH,
Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: One-year follow-up results.
Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: The.
Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data.
NT–probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non–ST-elevation acute coronary syndromes  José.
Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation  Anh L. Bui, MD, Maria.
National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance  Judith.
Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.
Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right.
Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: The.
Volume 9, Issue 1, Pages (January 2012)
Long-term mechanical circulatory support: A new disease state?
Coronary artery-to-left ventricular fistula
King of Hearts for Ace of Spades: Apical Hypertrophic Cardiomyopathy
Francesca Mallamaci, MD, Giovanni Tripepi, PhD 
Pseudotumor Cerebri: Early Manifestation of Adult Lyme Disease
Familial Ebstein's anomaly, left ventricular noncompaction, and ventricular septal defect associated with an MYH7 mutation  Keiichi Hirono, MD, Yukiko.
The Impact of Race on the Prognosis of Preclinical Diastolic Dysfunction: A Large Multiracial Urban Population Study  Jian Shan, MD, Lili Zhang, MD, MSc,
Optimized Group Sequential Study Designs for Tests of Genetic Linkage and Association in Complex Diseases  Inke R. König, Helmut Schäfer, Hans-Helge Müller,
Jimmy Mbogori, MD, Karan Chawdhary, James L. Vacek, MD 
Misconceptions and Facts About Hypertrophic Cardiomyopathy
DMRT1 mutations are rarely associated with male infertility
Prospective follow-up study of children with univentricular heart: Neurodevelopmental outcome at age 12 months  Anne Sarajuuri, MD, Tuula Lönnqvist, MD,
Jayme E. Locke, MD, MPH  American Journal of Kidney Diseases 
The American Journal of Human Genetics 
Genetic Pathogenesis of Hypertrophic and Dilated Cardiomyopathy
The Effects of Candesartan on Left Ventricular Hypertrophy and Function in Nonobstructive Hypertrophic Cardiomyopathy  Martin Penicka, Pavel Gregor, Roman.
Christoph Lange, Nan M. Laird  The American Journal of Human Genetics 
The Origins of Hypertrophic Cardiomyopathy–Causing Mutations in Two South African Subpopulations: A Unique Profile of Both Independent and Founder Events 
Genetic Investigation of Quantitative Traits Related to Autism: Use of Multivariate Polygenic Models with Ascertainment Adjustment  Yun Ju Sung, Geraldine.
Rescue Bariatric Surgery for Obesity-induced Cardiomyopathy
The Malnourished Heart: An Unusual Case of Heart Failure
The Reply The American Journal of Medicine
Insomnia in the Elderly: Cause, Approach, and Treatment
Niv Ad, MD, Lawrence M. Wei, MD 
‘The sedentary heart’: Physical inactivity is associated with cardiac atrophy in adults with an intellectual disability  Jeroen C. Vis, Rianne H. de Bruin-Bon,
Familial long QT syndrome and late development of dilated cardiomyopathy in a child with a KCNQ1 mutation: A case report  Kiona Y. Allen, MD, Victoria.
Position of the American Dietetic Association: Individual-, Family-, School-, and Community-Based Interventions for Pediatric Overweight    Journal of.
Volume 72, Issue 5, Pages (November 1977)
Physiologic left ventricular reconstruction: Shape, function, and time recaptured  Gerald D. Buckberg, MD  The Journal of Thoracic and Cardiovascular Surgery 
In the Literature: Cognitive Impairment in Hemodialysis Patients
This Month in AJKD American Journal of Kidney Diseases
The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids  Paul.
Falls in Older Adults: Risk Assessment, Management and Prevention
A grayscale photograph with high dynamic range taken under a Wood's lamp for better recognition of vitiligo lesions  Jung Min Bae, MD, PhD, Tae Young.
Emily G. McDonald, MD, MSc, Ramy R. Saleh, MD, Todd C. Lee, MD, MPH 
Lipomatous septal hypertrophy
Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy 
β-Blocker Use for the Stages of Heart Failure
Hypophosphatemia: Diagnostic Significance in Legionnaires’ Disease
Presentation transcript:

Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy–causing mutations in the β-myosin heavy chain, α- tropomyosin, and myosin-binding protein C genes  Tuija Poutanen, MD, Tero Tikanoja, MD, Pertti Jääskeläinen, MD, Eero Jokinen, MD, Annuli Silvast, MSc, Markku Laakso, MD, Johanna Kuusisto, MD  American Heart Journal  Volume 151, Issue 3, Pages 725.e1-725.e9 (March 2006) DOI: 10.1016/j.ahj.2005.12.005 Copyright © 2006 Mosby, Inc. Terms and Conditions

Figure 1 The maximal septum thickness on 2DE in children from HCM families. Genetically affected children and unaffected children are marked with different marks. The dashed lines represent the 95th and 5th percentile values of 2DE septum thickness in 168 healthy children and young adults adjusted for BSA (0.1 m2 groups, 6−21 subjects per group, mean age of subjects 11.1 [SD 5.1] years, range 2.1-27 years). American Heart Journal 2006 151, 725.e1-725.e9DOI: (10.1016/j.ahj.2005.12.005) Copyright © 2006 Mosby, Inc. Terms and Conditions

Figure 2 A, IVRT values in children with disease-causing mutations (G+) and genetically unaffected (G−) and matched control children. The dashed line represents +2SD value of the control children. B, SD scores of 3DE LA maximum volume of G+, G−, and control children. The dashed line represents +2SD scores. C, NT-proANP values in genetically affected, genetically unaffected (G−), and control children. The dashed line represents the NT-proANP 90th percentile value (0.19 nmol/L) in the control group. The dotted line represents the detection limit of the method (0.1 nmol/L). MYH7, The Arg719Trp mutation of the β-myosin heavy chain gene; TPM1, the Asp175Asn mutation of the α-tropomyosin gene; MYBPC3 Gln1061X, the Gln1061X mutation of the myosin-binding protein C gene (MYBPC3); MYBPC3 IVS5-2A→C, the IVS5-2A→C mutation of the MYBPC3 gene. American Heart Journal 2006 151, 725.e1-725.e9DOI: (10.1016/j.ahj.2005.12.005) Copyright © 2006 Mosby, Inc. Terms and Conditions

Figure 3 A, Reconstruction of LA and LV maximum volumes in a 3.5-year-old child with the Arg719Trp mutation of the β-myosin heavy chain gene by 3DE. B, Averaged LA and LV time-volume curves during the heart cycle in genetically affected (G+) children (n = 27) and control children (upper panel) and in genetically unaffected (G−) children (n = 26) and control children (lower panel). The darker lines represent the children from HCM families (G+ or G−) and the lighter lines represent the matched control children. American Heart Journal 2006 151, 725.e1-725.e9DOI: (10.1016/j.ahj.2005.12.005) Copyright © 2006 Mosby, Inc. Terms and Conditions